Skip to main content
Log in

Adrenergic blocking agents: Their use in clinical medicine

  • Published:
The American Journal of Digestive Diseases

Summary

In the past one has been able to affect the autonomic nervous system to a varying degree in most respects except in depression of the sympathetic or adrenergic nervous system ; but the latter is now becoming a reality in certain respects. The problem of applying adrenergic blockade has been attacked and encouraging results have been obtained so that the medical profession can now treat the varied syndrome of sympathetic predominance. Vasospastic conditions of the vascular tree, including neurogenic or essential hypertension, are peculiarly susceptible in many instances to adrenergic blockade, and it behooves the medical profession to become more aware of the role of sympatholytics and the newer suppressants of sympathetic overflow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Berry. R. L.. Campbell. K. N.. Lvons. R. L., Moe. G. K. and Sutler. M. R.: The Use of Tetraethvlammouium in Peripheral Vascular Diseases and Causalgic Studies. Surgery, 20: 525, 1946.

    Google Scholar 

  2. Fellows. E. J., Macko. E., McLean, R. A., Kerwin, J. F., Hall. G.. Milnes, F. J. and Ullvot. G. E.: A Comparison of the Oral and Intravenous Adrenergic Blocking Activitv of a Number of Beta-bromo and Chloro-alkylamines. Jl. Pharm. & Exp. Ther. 101: 11. Jan. 1951.

    Google Scholar 

  3. Rothlin. E.: The Pharmacology of the Natural and Dihvdrogenated Alkaloids of Ergot. Bull. Acad. Suisse. Se. Med. 2: 1. 1946/47.

    Google Scholar 

  4. Grimson. K. S., Reardon, M. J. Marzoni, F. A. and Herrix. J. P.: The Effects of Priscol (2-benzyl-4. 5-imidazoliue HCI) on Peripheral Vascular Diseases. Hypertension and Circulation in Patients. Ann. Surg, 127: 968. 1948. Rogers, M. P.: Use of Sympatholvtie Dvuer (Priscol) from the Point of View a General Surgicnl Practitioner. J. A. M. A. 140: 272, May 21, 1949.

    Article  PubMed  CAS  Google Scholar 

  5. Meier, R.. Yonkman. F. F.. Carver. B. N. and Gross, F.: A New Imidazoline Derivative with Marked Adrenolvtic Properties. Proc. Soc. Exper. Biol. & Med. 71: 70, 1949.

    CAS  Google Scholar 

  6. Gross, F., Druey, J. and Meier. R.: A New Group of Depressor Substances with a Special Type of Effect. Experentia 6: 19, 1950. Freis, E. D. and Fiunerty, F. A., Jr.: Suppression of Vasomotor Reflexes in Man Following l-Hydrazinophthalazine (C-5968). Proc. Soc. Exper. Biol. and Med. 75: 23, Oct., 1950.

    Article  CAS  Google Scholar 

  7. Freis, E. D., Finnerty, Jr., F. A., and Walsh, W. B.: The Treatment of Severe Essential Hypertension. Medical Clinics of North America, 34: 1741, November, 1950. Yonkman, F. F., and Freis, E. D.: Rational Elimination of Side Reactions and/or Tolerance in the Development of Potentially Valuable Drugs. Aniology, 3:36, Feb. 1952.

    PubMed  CAS  Google Scholar 

  8. Schroeder, H. A.: Effects of Hypertension of Sulfhydryl and Hydrazine Compounds. Jl. Clin. Inves. June, 1951.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rogers, M.P., Yonkman, F.F. Adrenergic blocking agents: Their use in clinical medicine. Amer. Jour. Dig. Dis. 19, 144–146 (1952). https://doi.org/10.1007/BF02893204

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02893204

Keywords

Navigation